AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31848889 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus Early Enteral Nutrition (EEN)
Number of subjects: 200
Study 31848889 — intervention group
Group type: COMPARATOR
Intervention: Conventional
Number of subjects: 200
Study 31848889 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus Conventional
Number of subjects: 200
Study 31848889 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Enteral Nutrition (EEN)
Number of subjects: 200
Study 28949056 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise tolerance testing (ETT) in RAND-CFR patients
Number of subjects: 20
Study 28949056 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (n=9) without diabetes
Number of subjects: 20
Study 27777094 — intervention group
Group type: EXPERIMENTAL
Intervention: NO3‐rich beetroot juice (BR; 70 mL·day‐1; 6.4 mmol of NO3‐)
Number of subjects: 36
Study 24615411 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced expression of competence
Number of subjects: 345
Study 24615411 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced expression of honesty
Number of subjects: 345
Study 24615411 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced expression of caring
Number of subjects: 345
Study 24615411 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication of honesty and caring
Number of subjects: 345
Study 23289279 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (PEMF) therapy for 10 days during cast immobilization
Number of subjects: 60
Study 23289279 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PEMF therapy)
Number of subjects: 60
Study 20946748 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived approval of close friends
Number of subjects: 3753
Study 20946748 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived approval of typical students
Number of subjects: 3753
Study 20946748 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental approval
Number of subjects: 3753
Study 18675396 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week device-supported isolated lumbar extension training, twice a week
Number of subjects: 129
Study 18675396 — intervention group
Group type: COMPARATOR
Intervention: Regular physical therapy mainly consisting of exercise therapy and aerobic activities
Number of subjects: 129
Study 15726102 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual mammography screening from age 40 to 41
Number of subjects: 160921
Study 15726102 — intervention group
Group type: COMPARATOR
Intervention: 3-yearly UK national programme invitation at age 50-52
Number of subjects: 160921
Study 12854090 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV-16 L1 VLP vaccine
Number of subjects: 43
Study 12854090 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 10596514 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive coping skills training added to operant-behavioral treatment (OPCO)
Number of subjects: 0
Study 10596514 — intervention group
Group type: EXPERIMENTAL
Intervention: Operant program + group discussion (OPDI)
Number of subjects: 0
Study 10596514 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control (WLC)
Number of subjects: 0
Study 10596514 — intervention group
Group type: COMPARATOR
Intervention: Less protocolized operant program (OPUS)
Number of subjects: 0
Study 8692556 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron
Number of subjects: 0
Study 8692556 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron plus dexamethasone
Number of subjects: 0
Study 1725444 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg lacidipine with 160 mg propranolol
Number of subjects: 24
Study 1725444 — intervention group
Group type: EXPERIMENTAL
Intervention: 160 mg propranolol with 4 mg lacidipine
Number of subjects: 24
Study 1725444 — intervention group
Group type: COMPARATOR
Intervention: 4 mg lacidipine alone
Number of subjects: 24
Study 1725444 — intervention group
Group type: COMPARATOR
Intervention: 160 mg propranolol alone
Number of subjects: 24
Study 6617712 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (650 mg single dose)
Number of subjects: 32
Study 30857862 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral Superficial Cervical Plexus Block (BSCPB)
Number of subjects: 70
Study 30857862 — intervention group
Group type: COMPARATOR
Intervention: Local Wound Infiltration (LWI)
Number of subjects: 70
Study 28177460 — intervention group
Group type: EXPERIMENTAL
Intervention: trastuzumab
Number of subjects: 203
Study 28177460 — intervention group
Group type: EXPERIMENTAL
Intervention: lapatinib
Number of subjects: 203
Study 28177460 — intervention group
Group type: EXPERIMENTAL
Intervention: lapatinib + trastuzumab
Number of subjects: 203
Study 28177460 — intervention group
Group type: EXPERIMENTAL
Intervention: trastuzumab alone
Number of subjects: 203
Study 28177460 — intervention group
Group type: EXPERIMENTAL
Intervention: lapatinib added to trastuzumab
Number of subjects: 203
Study 26098027 — intervention group
Group type: EXPERIMENTAL
Intervention: EMA‐EMI condition (Ecological Momentary Intervention with text messages promoting moderation)
Number of subjects: 130
Study 26098027 — intervention group
Group type: COMPARATOR
Intervention: EMA condition (Ecological Momentary Assessment)
Number of subjects: 130
Study 24289736 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 490
Study 24289736 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 490
Study 21332627 — intervention group
Group type: EXPERIMENTAL
Intervention: Saxagliptin 2.5 mg once daily
Number of subjects: 170
Study 21332627 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 170
Study 19095839 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung recruitment maneuver (RM)
Number of subjects: 0
Study 19095839 — intervention group
Group type: COMPARATOR
Intervention: Control group (no RM)
Number of subjects: 0
Study 17761914 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric oxygen therapy (NBO)
Number of subjects: 0
Study 17761914 — intervention group
Group type: COMPARATOR
Intervention: Room air (Control)
Number of subjects: 0
Study 14600537 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Cord Stimulation (SCS)
Number of subjects: 0
Study 11022983 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g intravenous MgSO4
Number of subjects: 34
Study 11022983 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sterile water)
Number of subjects: 34
Study 9104904 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral propafenone (mean dose 663 +/- 99 mg/day)
Number of subjects: 79
Study 9104904 — intervention group
Group type: COMPARATOR
Intervention: Oral sotalol (mean dose 200 +/- 57 mg/day)
Number of subjects: 79
Study 9104904 — intervention group
Group type: COMPARATOR
Intervention: Comparison of intolerable side effects
Number of subjects: 79
Study 9104904 — intervention group
Group type: COMPARATOR
Intervention: Comparison of tolerable side effects
Number of subjects: 79
Study 9104904 — intervention group
Group type: COMPARATOR
Intervention: Comparison of attack frequency at baseline
Number of subjects: 79
Study 9104904 — intervention group
Group type: COMPARATOR
Intervention: Comparison of attack frequency after treatment
Number of subjects: 79
Study 9104904 — intervention group
Group type: COMPARATOR
Intervention: Comparison of effective response to drugs
Number of subjects: 79
Study 9104904 — intervention group
Group type: COMPARATOR
Intervention: Comparison of decrease of symptom scores
Number of subjects: 79
Study 9104904 — intervention group
Group type: COMPARATOR
Intervention: Comparison of percentage decrease of ventricular rate during AF
Number of subjects: 79
Study 1436603 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg heparan sulfate
Number of subjects: 9
Study 1436603 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg heparan sulfate
Number of subjects: 9
Study 1436603 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 2947099 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract
Number of subjects: 0
Study 2947099 — intervention group
Group type: COMPARATOR
Intervention: Nicergoline (standard alpha blocker)
Number of subjects: 0
Study 29751254 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric pre-conditioning (IPC) with 10 maximal voluntary isometric contractions (MVIC) in a leg press machine two days prior to downhill running
Number of subjects: 30
Study 29751254 — intervention group
Group type: COMPARATOR
Intervention: Control group (no IPC)
Number of subjects: 30
Study 29751254 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric pre-conditioning (IPC)
Number of subjects: 30
Study 26634419 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid 81 mg daily with 50 mg losartan
Number of subjects: 28
Study 26634419 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid 81 mg every 3 days with 50 mg losartan
Number of subjects: 28
Study 26634419 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 28
Study 25431866 — intervention group
Group type: COMPARATOR
Intervention: iAMP21 cases (n=14) in the MRD low-risk group
Number of subjects: 46
Study 25431866 — intervention group
Group type: COMPARATOR
Intervention: iAMP21 cases (n=27) in the MRD intermediate-risk group
Number of subjects: 46
Study 25431866 — intervention group
Group type: COMPARATOR
Intervention: Non-iAMP21 patients
Number of subjects: 46
Study 22607698 — intervention group
Group type: EXPERIMENTAL
Intervention: Care pathway for PFF or COPD containing three active components: formative evaluation of team performance, evidence-based key interventions, training in care pathway development.
Number of subjects: 132
Study 22607698 — intervention group
Group type: EXPERIMENTAL
Intervention: Care pathway for PFF or COPD.
Number of subjects: 132
Study 22607698 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 132
Study 20413513 — intervention group
Group type: EXPERIMENTAL
Intervention: INCB13739 200 mg
Number of subjects: 302
Study 20413513 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302
Study 18317667 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-based exercise program
Number of subjects: 40
Study 18317667 — intervention group
Group type: COMPARATOR
Intervention: Home-based exercise program
Number of subjects: 40
Study 16037732 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 0.1 mg
Number of subjects: 80
Study 16037732 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine 2 mg
Number of subjects: 80
Study 16037732 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 0.25% paraspinal muscle infiltration (30 mL)
Number of subjects: 80
Study 16037732 — intervention group
Group type: COMPARATOR
Intervention: Saline paraspinal muscle infiltration (30 mL)
Number of subjects: 80
Study 12512988 — intervention group
Group type: EXPERIMENTAL
Intervention: Crest SpinBrush (experimental toothbrush)
Number of subjects: 39
Study 12512988 — intervention group
Group type: COMPARATOR
Intervention: Colgate Actibrush (control toothbrush)
Number of subjects: 39
Study 10661525 — intervention group
Group type: EXPERIMENTAL
Intervention: Prototype 1
Number of subjects: 10
Study 10661525 — intervention group
Group type: EXPERIMENTAL
Intervention: Prototype 2 with wrist splint
Number of subjects: 10
Study 10661525 — intervention group
Group type: EXPERIMENTAL
Intervention: Platform Cane (PC)
Number of subjects: 10
Study 10661525 — intervention group
Group type: COMPARATOR
Intervention: Standard Cane (SC)
Number of subjects: 10
Study 8752794 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine stress echocardiography
Number of subjects: 120
Study 8752794 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine stress echocardiography
Number of subjects: 120
Study 8752794 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress echocardiography (both dobutamine and adenosine)
Number of subjects: 120
Study 8752794 — intervention group
Group type: EXPERIMENTAL
Intervention: ST segment depression (≥ 1mm) during dobutamine test
Number of subjects: 120
Study 2014968 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 22
Study 7138270 — intervention group
Group type: EXPERIMENTAL
Intervention: Air pressure splint treatment for 5 consecutive days
Number of subjects: 30
Study 7138270 — intervention group
Group type: COMPARATOR
Intervention: Control hand (no treatment)
Number of subjects: 30
Study 31385663 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe co-morbidity (CIRS-G score grades 3 and 4)
Number of subjects: 436
Study 31385663 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe heart disease
Number of subjects: 436
Study 31385663 — intervention group
Group type: EXPERIMENTAL
Intervention: CIRS-G score
Number of subjects: 436
Study 31385663 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletal Muscle Index (SMI)
Number of subjects: 436
Study 31385663 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear regression analysis
Number of subjects: 436
Study 27615562 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80mg and ezetimibe 10mg
Number of subjects: 61
Study 27615562 — intervention group
Group type: COMPARATOR
Intervention: Routine statin therapy
Number of subjects: 61
Study 26540594 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratafix bidirectional barbed suture
Number of subjects: 47
Study 26540594 — intervention group
Group type: COMPARATOR
Intervention: Conventional suture
Number of subjects: 47
Study 25365686 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored communication interventions via interactive voice response (IVR) call, graded segments for outreach.
Number of subjects: 46697
Study 25365686 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving no communication.
Number of subjects: 46697
Study 22288661 — intervention group
Group type: EXPERIMENTAL
Intervention: High soft drink consumers
Number of subjects: 0
Study 22288661 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdependence-primed participants
Number of subjects: 0
Study 22288661 — intervention group
Group type: EXPERIMENTAL
Intervention: Asian-Americans
Number of subjects: 0
Study 22288661 — intervention group
Group type: EXPERIMENTAL
Intervention: High soft drink consumers (Chinese)
Number of subjects: 0
Study 22288661 — intervention group
Group type: COMPARATOR
Intervention: Low soft drink consumers
Number of subjects: 0
Study 22288661 — intervention group
Group type: COMPARATOR
Intervention: Independence-primed participants
Number of subjects: 0
Study 22288661 — intervention group
Group type: COMPARATOR
Intervention: European-North Americans
Number of subjects: 0
Study 19104182 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated regular bolus of 0.125% levobupivacaine (n = 25)
Number of subjects: 50
Study 19104182 — intervention group
Group type: COMPARATOR
Intervention: Continuous infusion of 0.125% levobupivacaine (n = 25)
Number of subjects: 50
Study 19104182 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Automated bolus and Continuous infusion)
Number of subjects: 50
Study 17983296 — intervention group
Group type: EXPERIMENTAL
Intervention: Happy emotional state
Number of subjects: 0
Study 17983296 — intervention group
Group type: EXPERIMENTAL
Intervention: Sad emotional state
Number of subjects: 0
Study 17983296 — intervention group
Group type: COMPARATOR
Intervention: Neutral affect control
Number of subjects: 0
Study 17983296 — intervention group
Group type: EXPERIMENTAL
Intervention: High elaboration conditions
Number of subjects: 0
Study 17983296 — intervention group
Group type: EXPERIMENTAL
Intervention: Low motivation to think
Number of subjects: 0
Study 16027401 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT‐578 (200, 400, or 800 microg) as daily intravenous infusions for 14 days
Number of subjects: 0
Study 16027401 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12381339 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine-enriched TPN (0.3 g/kg L-alanine-L-glutamine)
Number of subjects: 28
Study 12381339 — intervention group
Group type: COMPARATOR
Intervention: Standard TPN (1.5 g/kg body weight protein)
Number of subjects: 28
Study 12381339 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine-enriched TPN
Number of subjects: 28
Study 9619493 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous t-PA (tissue plasminogen activator) at a dose of 0.9 mg/kg, administered within 3 hours of symptom onset
Number of subjects: 0
Study 9619493 — intervention group
Group type: COMPARATOR
Intervention: Aspirin, heparin, and low‐molecular‐weight heparin products
Number of subjects: 0
Study 9619493 — intervention group
Group type: COMPARATOR
Intervention: Streptokinase
Number of subjects: 0
Study 9619493 — intervention group
Group type: COMPARATOR
Intervention: Thrombolytic agents
Number of subjects: 0
Study 8110571 — intervention group
Group type: EXPERIMENTAL
Intervention: Tape-recorded lists of 10 neutral words presented during anaesthesia.
Number of subjects: 48
Study 8110571 — intervention group
Group type: COMPARATOR
Intervention: Blank tape (control group).
Number of subjects: 48
Study 2540373 — intervention group
Group type: EXPERIMENTAL
Intervention: KHCO3, 60 mmol/day for 12 days
Number of subjects: 10
Study 2540373 — intervention group
Group type: COMPARATOR
Intervention: NaHCO3, 60 mmol/day for 12 days
Number of subjects: 10
Study 6997743 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine lung heparin
Number of subjects: 149
Study 6997743 — intervention group
Group type: EXPERIMENTAL
Intervention: Intestinal-mucosa A heparin
Number of subjects: 149
Study 6997743 — intervention group
Group type: EXPERIMENTAL
Intervention: Intestinal-mucosa O heparin
Number of subjects: 149
Study 6997743 — intervention group
Group type: COMPARATOR
Intervention: Combined intestinal-mucosa A and O
Number of subjects: 149
Study 29800420 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated Telephone Follow-up (ATF)
Number of subjects: 440
Study 29800420 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 440
Study 28145739 — intervention group
Group type: EXPERIMENTAL
Intervention: Seated heel raising and lowering
Number of subjects: 21
Study 28145739 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral standing heel raising and lowering
Number of subjects: 21
Study 28145739 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral heel raising and unilateral lowering
Number of subjects: 21
Study 28145739 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral heel raising and lowering
Number of subjects: 21
Study 25237150 — intervention group
Group type: EXPERIMENTAL
Intervention: Peaceful Buddhist music video (MV) intervention for 30 minutes before bedtime
Number of subjects: 38
Study 25237150 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control condition
Number of subjects: 38
Study 24054431 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral propranolol (0.25 or 0.5 mg/kg/6 hours) added to standard treatment
Number of subjects: 52
Study 24054431 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 52
Study 21252728 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of equol supplement per day
Number of subjects: 93
Study 21252728 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 20037095 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic radial artery harvesting (ERAH) with the VasoView system (Boston Scientific)
Number of subjects: 50
Study 20037095 — intervention group
Group type: COMPARATOR
Intervention: Traditional open technique for radial artery harvesting
Number of subjects: 50
Study 17766528 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (provider training, psychosocial screening tool, access to resource book)
Number of subjects: 200
Study 17766528 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 200
Study 17409978 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective mediastinoscopy
Number of subjects: 566
Study 17409978 — intervention group
Group type: COMPARATOR
Intervention: Routine mediastinoscopy
Number of subjects: 566
Study 14612326 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 messages generated by 20 female speakers in five elocution styles
Number of subjects: 200
Study 14612326 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 messages evaluated according to 20 criteria extracted from the first experiment
Number of subjects: 200
Study 10489653 — intervention group
Group type: EXPERIMENTAL
Intervention: Attendance at a memory clinic
Number of subjects: 50
Study 9156885 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical Plant (M.P. group 1)
Number of subjects: 264
Study 9156885 — intervention group
Group type: COMPARATOR
Intervention: Design Office (D.O. Group II)
Number of subjects: 264
Study 1743329 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) cotreatment
Number of subjects: 25
Study 7134840 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 45
Study 7134840 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc-DIDA cholescintigraphy
Number of subjects: 45
Study 7134840 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion tomography
Number of subjects: 45
Study 31657614 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 50
Study 31657614 — intervention group
Group type: COMPARATOR
Intervention: Aerobic Interval Training (AIT)
Number of subjects: 50
Study 30285672 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdiagnostic group CBT (tCBT) - 12 weekly 2-hour group sessions following a manualized treatment protocol
Number of subjects: 0
Study 30285672 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU) for anxiety disorders
Number of subjects: 0
Study 26822537 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management cues + incentive (free dental treatment)
Number of subjects: 112
Study 26822537 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 112
Study 24439713 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthetic putty
Number of subjects: 110
Study 24439713 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine infiltration
Number of subjects: 110
Study 22341824 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including strengthened STI syndromic management, mobile-team outreach for STI screening, presumptive treatment for trichomoniasis, and condom promotion.
Number of subjects: 15261